益气养心定志方治疗慢性阻塞性肺疾病患者焦虑状态临床研究
2018-09-25吴蔚王彬刘惠梅杨国华高峰
吴蔚 王彬 刘惠梅 杨国华 高峰
摘要:目的 观察益气养心定志方对慢性阻塞性肺疾病(COPD)患者焦虑状态的影响。方法 采用区组随机、平行对照、单盲法将80例患者分为观察组和对照组各40例。2组均予COPD稳定期维持治疗,在此基础上,观察组予益气养心定志方颗粒,对照组予中药模拟颗粒,每日1剂,每日2次冲服。连续治疗2周。观察2组治疗前后中医症状评分、慢性阻塞性肺疾病评估测试(CAT)评分、汉密顿焦虑量表(HAMA)评分,并监测安全性指标。结果 与本组治疗前比较,2组治疗后中医症状评分、CAT评分、HAMA评分明显降低(P<0.05);治疗后观察组和对照组中医症状总分改善程度[(5.04±1.90)分vs(2.27±1.83)分]、CAT评分改善程度[(4.51±1.36)分vs(1.81±1.47)分]及HAMA总分改善程度[(5.32±2.78)分vs(2.76±1.19)分]比较,观察组优于对照组,差异有统计学意义(P<0.05)。2组均未发生明显不良事件。结论 益气养心定志方可有效缓解稳定期COPD患者的焦虑状态,改善其生活质量,安全性良好。
关键词:慢性阻塞性肺疾病;焦虑状态;益气养心定志方
DOI:10.3969/j.issn.1005-5304.2018.07.007
中图分类号:R259.63 文献标识码:A 文章编号:1005-5304(2018)07-0025-05
Abstract: Objective To observe the effects of Yiqi Yangxin Dingzhi Prescription on anxiety state of patients with chronic obstructive pulmonary disease (COPD). Methods Randomized, parallel controled, single-blind research plan was used. Totally 80 patients with COPD were randomly divided into observation group and control group, with 40 cases in each group. Both groups received COPD stable maintenance treatment. On this basis, observation group was given Yiqi Yangxin Dingzhi Granules, while control group was given TCM simulator, one dosage per day, twice a day. The treatment lasted for two weeks both groups. TCM symptom scores, COPD assessment test (CAT) scores, and Hamilton Anxiety Scale (HAMA) scores before and after treatment in the two groups were observed. The safety indexes were monitored. Results Compared with before treatment, the TCM symptom scores, CAT scores, and HAMA scores of the two groups after treatment were significantly lower (P<0.05). After treatment, the improvement degree of the TCM symptom total scores [(5.04±1.90) vs (2.27±1.83), the improvement degree of the CAT total score [(4.51±1.36) vs (1.81±1.47)], and the improvement degree of the HAMA total score [(5.32±2.78) vs (2.76±1.19)] in the observation group were better than the control group, with statistical significance (P<0.05). No significant adverse events occurred in both groups. Conclusion Yiqi Yangxin Dingzhi Prescription can effectively improve the clinical symptoms of the patients with COPD and the life quality of the patients, and it has high safety.
Keywords: chronic obstructive pulmonary disease; anxiety state; Yiqi Yangxin Dingzhi Prescription
慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是一種进行性发展的慢性疾病,急性加重期与稳定期交替出现。稳定期患者的症状有所改善,但肺功能进行性下降所致的日常活动受限持续存在,呼吸道及全身防御机能的下降又导致呼吸道感染及病情急性加重的反复发生,对患者情绪产生负面影响。因此,焦虑/抑郁成为COPD常见的合并症,加剧病情的进展恶化[1]。目前,临床对COPD合并焦虑、抑郁的识别诊断率低、缺乏安全有效的治疗手段。笔者采用益气养心定志方对COPD合并焦虑状态进行干预,现报道如下。
1 资料与方法
1.1 一般资料
选择2015年8月-2016年7月本院COPD稳定期合并焦虑状态患者80例。采用区组随机、平行对照、单盲法分为观察组和对照组各40例。对照组剔除1例(复查肺功能后排除COPD诊断)。观察组男性28例,女性12例;……